Serina Historical Balance Sheet
| SER Stock | 6.00 0.47 8.50% |
Trend analysis of Serina Therapeutics balance sheet accounts such as Total Stockholder Equity of 5.7 M, Property Plant And Equipment Net of 519.9 K, Current Deferred Revenue of 0.95 or Net Debt of 2.4 M provides information on Serina Therapeutics' total assets, liabilities, and equity, which is the actual value of Serina Therapeutics to its prevalent stockholders. By breaking down trends over time using Serina Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Serina Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Serina Therapeutics is a good buy for the upcoming year.
Serina Therapeutics Inventory |
|
Serina |
About Serina Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Serina Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Serina Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Serina Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Serina currently owns. An asset can also be divided into two categories, current and non-current.
Serina Therapeutics Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Serina Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Serina Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Serina Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Serina Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Net Debt
The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.Long Term Debt
Long-term debt is a debt that Serina Therapeutics has held for over one year. Long-term debt appears on Serina Therapeutics balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Serina Therapeutics balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.Most accounts from Serina Therapeutics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Serina Therapeutics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Serina Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Serina Stock, please use our How to Invest in Serina Therapeutics guide.At this time, Serina Therapeutics' Common Stock Shares Outstanding is relatively stable compared to the past year. As of 12/20/2024, Liabilities And Stockholders Equity is likely to grow to about 12.6 M, while Other Current Liabilities is likely to drop slightly above 791.5 K.
| 2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 398.2K | 1.8M | 4.4M | 3.3M | Total Assets | 1.8M | 858.0K | 12.0M | 12.6M |
Serina Therapeutics balance sheet Correlations
Click cells to compare fundamentals
Serina Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pair Trading with Serina Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Serina Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Serina Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Serina Stock
Moving against Serina Stock
| 0.75 | GILD | Gilead Sciences | PairCorr |
| 0.74 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
| 0.58 | DYAI | Dyadic International | PairCorr |
| 0.54 | ESPR | Esperion Therapeutics | PairCorr |
The ability to find closely correlated positions to Serina Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Serina Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Serina Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Serina Therapeutics to buy it.
The correlation of Serina Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Serina Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Serina Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Serina Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Serina Stock Analysis
When running Serina Therapeutics' price analysis, check to measure Serina Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Serina Therapeutics is operating at the current time. Most of Serina Therapeutics' value examination focuses on studying past and present price action to predict the probability of Serina Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Serina Therapeutics' price. Additionally, you may evaluate how the addition of Serina Therapeutics to your portfolios can decrease your overall portfolio volatility.